ask="19.650"
ask_size="100"
average_daily_volume="1655100"
bid="17.520"
bid_size="400"
book_value="10.762"
change="+0.015"
change_from_200_day_moving_average="0.738"
change_from_50_day_moving_average="1.908"
change_from_52_week_high="-20.605"
change_From_52_week_low="3.985"
change_in_percent="+0.078%"
close="19.135"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.885"
ebitda="143.80M"
eps_estimate_current_year="0.990"
eps_estimate_next_quarter="0.270"
eps_estimate_next_year="1.070"
ex_dividend_date="7/1/2009"
float_shares="60261000"
high="19.480"
high_52_weeks="39.740"
last_trade_date="3/8/2017"
last_trade_price="19.135"
last_trade_size="83016"
last_trade_time="4:00pm"
low="18.910"
low_52_weeks="15.150"
market_capitalization="1.30B"
moving_average_200_day="18.397"
moving_average_50_day="17.227"
name="Myriad Genetics
Inc."
notes="N/A"
one_year_target_price="19.090"
open="19.150"
pe_ratio="21.621"
peg_ratio="-6.310"
percent_change_from_200_day_moving_average="+4.009%"
percent_change_from_50_day_moving_average="+11.078%"
percent_change_from_52_week_high="-51.850%"
percent_change_from_52_week_low="+26.304%"
previous_close="19.120"
price_eps_estimate_current_year="19.328"
price_eps_Estimate_next_year="17.883"
price_per_book="1.777"
price_per_sales="1.734"
revenue="750.90M"
shares_outstanding="68091000"
short_ratio="11.780"
stock_exchange="NMS"
symbol="MYGN"
volume="1289885"
weeks_range_52="15.150 - 39.740"
